NHSL3 and non-small cell lung carcinoma: Our study extends findings by evaluating KIAA1522's role through NSCLC samples via immunohistochemistry (IHC), assessing survival rates and relapse-progression, and constructing hazard models incorporating clinicopathological features and KIAA1522 expression patterns.